Asymptomatic SARS-CoV-2 infection in children in children – if and how should they be monitored in the following months of the pandemic?
Sylwia Chodubska | Anna Opyrchał | Agnieszka Wypych | Anna Komaszyńska | Paweł Grzesiowski | Agnieszka Sulikowska
Assessment of the in vitro sensitivity of bacterial pathogens to ceftaroline and comparator antibiotics Frequently Used in Poland in skin and soft tissue infections in paediatric and adult populations: data from ATLAS surveillance program 2013–2018
Małgorzata B. Prażyńska | Łukasz Pojnar | Patrycja Zalas-Więcek | Eugenia Gospodarek-Komkowska | Jolanta Kędzierska | Anna Kujawska | Barbara Możejko-Pastewka | Monika Bogiel
Prevention of infections in premature babies and newborns – which antiseptic should you choose?
Monika Oleksy-Wawrzyniak | Malwina Brożyna | Elżbieta Piątkowska | Kinga Niewińska | Marzenna Bartoszewicz
Carbapenems – microbiology and pharmacology
Jarosław Woroń | Beata Kowalska-Krochmal
Intravenous administration of amoxicillin/clavulanic acid at a dose of 2000 mg + 200 mg
Kinga Bondarczuk
Nitroxoline, a valuable therapeutic option in urinary tract infections
Jarosław Woroń
Microbiological tests in pregnant women – standards of conduct
Agnieszka Sikora | Anna Sikora-Futyma | Marzena Laskowska
Piotr Kacprzyk